The eater 2-deoxy-D-glucose tetraacetate (2-DOGTA) was recently shown to di
splay cytostatic and cytotoxic activity in various lines of tumoral cells.
In the present work, it was found to inhibit cell growth and confer chemose
nsitivity to cisplatin in two lines of human melanoma cells, poorly respons
ive to cisplatin. The inhibition of cell growth by 2-DOGTA was apparently n
ot attributable to alteration of either D-glucose utilization or oxidation
in these melanoma cell lines. In freshly isolated human melanoma cells, 2-D
OGTA also inhibited cell growth, even in cells resistant to standard chemot
herapeutic agents, such as temozolomide, cisplatin and/or vindesine. It is
proposed, therefore, that 2-DOGTA should be further investigated for the tr
eatment of melanoma patients, whether alone or in combination with known ch
emotherapeutic agents.